Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3993790017 | Canakinumab only product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3993791018 | Product containing only canakinumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Canakinumab only product in parenteral dose form | Is a | Canakinumab-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Canakinumab only product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
| Canakinumab only product in parenteral dose form | Is a | Canakinumab only product | true | Inferred relationship | Some | ||
| Canakinumab only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Canakinumab only product in parenteral dose form | Has active ingredient | Canakinumab | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Canakinumab 150 mg/mL solution for injection | Is a | True | Canakinumab only product in parenteral dose form | Inferred relationship | Some | |
| Canakinumab 150 mg lyophilised powder for solution for injection vial | Is a | False | Canakinumab only product in parenteral dose form | Inferred relationship | Some | |
| Canakinumab 150 mg powder for solution for injection vial | Is a | True | Canakinumab only product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR